Life Sciences
Major pharmacies and services say they're unaffected by USPS troubles so far, but some online platforms that rely on the service are worried about their patients and long-term business.
The AI-enabled company works with pharma companies and research institutions on research and development for new medications.
The companies will also be looking into using Eko's tech in clinical trials.
The original focus will be on multiple sclerosis but will extend to include Huntington's disease and hemophilia.
The connected inhaler's launch will be followed by Teva's other Digihaler products before the end of the year.
With the service, pharmacists can compare multiple different medications and see how risky the combination is.
Providers can tap into the tool for resources and collaboration.
The co-packaged product, which will be launched in Europe this year, combines Propeller's sensor tech and Novartis' new medication.
The company's drug development CRO, Covance, will integrate Medable's software to expand its decentralized trial capabilities.
The platform will include an AI-enabled patient-engagement tool and smart pricing.